Comparative analysis of Peg-Interferon alpha-2b and Lamivudine in the treatment of chronic hepatitis B patients: Preliminary results

被引：1
|
作者：
Koliouskas, D [1 ]
Sidiropoulos, I [1 ]
Masmanidou, M [1 ]
Dokas, S [1 ]
Ziakas, A [1 ]
机构：
[1] AHEPA Gen Hosp, Thessaloniki, Greece
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80852-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
851
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [31] HBsAg seroclearance or seroconversion induced by peg-interferon alpha and lamivudine or adefovir combination therapy in chronic hepatitis B treatment: a meta-analysis and systematic review
    Zhang, Yun
    Chen, Bangtao
    Wang, Lin
    Chit, Junjie
    Song, Shaojuan
    Liu, Mingshe
    Zhao, Zhongfu
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2016, 108 (05) : 263 - 270
  • [32] Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin:: study of sixteen patients
    Rocca, P
    Bailly, FO
    Chevallier, M
    Chevallier, P
    Zoulim, F
    Trépo, C
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2003, 27 (03): : 294 - 299
  • [33] Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotheraphy in patients with chronic hepatitis B, a multicenter, randomized trial
    Barbaro, G
    Zechini, F
    Pellicelli, AM
    Francavilla, R
    Scotto, G
    Bacca, D
    Bruno, M
    Babudieri, S
    Annese, M
    Matarazzo, F
    Di Stefano, G
    Starnini, G
    Zocchetti, C
    Barbarini, G
    JOURNAL OF HEPATOLOGY, 2001, 34 : 136 - 136
  • [34] PEG-Interferon alfa2b plus ribavirin treatment in chronic hepatitis C
    Müller, T
    MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (12) : 1192 - 1192
  • [35] Editorial: the durability of seroconversion of hepatitis B e antigen in the treatment of chronic hepatitis B with PEG-interferon alfa-2a
    Wei, M. T.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (11) : 1556 - 1557
  • [36] High dose consensus interferon and ribavirin for treatment of chronic Hepatitis C infection in patients who are resistant to PEG-Interferon alfa-2b and ribavirin: Preliminary results
    Fernandez, AA
    Singh, S
    Victor, A
    Santiago, M
    Rothstein, KD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S93 - S94
  • [37] Treatment of chronic hepatitis C with a combination of interferon alpha-2b and cimetidine.
    Kubo, Y
    Yutoku, K
    Iida, Y
    Sakaida, I
    Okita, K
    HEPATOLOGY, 2002, 36 (04) : 287A - 287A
  • [38] Early prediction of nonresponders to treatment with interferon alpha-2b and ribavirin in patients with chronic hepatitis C
    Liu, LWC
    Tomlinson, G
    Mazzulli, T
    Murray, A
    Heathcote, J
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2003, 17 (08): : 483 - 487
  • [39] Combined treatment with interferon alpha-2b and cyclosporin A for chronic hepatitis C.
    Inoue, K
    Yoshiba, M
    HEPATOLOGY, 1997, 26 (04) : 1886 - 1886
  • [40] Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection
    Puoti, M
    Rossi, S
    Forleo, MA
    Zaltron, S
    Spinetti, A
    Putzolu, V
    Rodella, A
    Carosi, G
    JOURNAL OF HEPATOLOGY, 1998, 29 (01) : 45 - 52
12345